TMA EVPGram

Over TMA’s objections, the U.S. Drug Enforcement Administration announced it will reclassify drugs that contain hydrocodone combinations from Schedule III to Schedule II. The change takes effect Oct. 6. We’ve already received numerous calls in the TMA Knowledge Center from physicians concerned about how this will affect their patients and their practices. TMA has prepared a short question-and-answer document that explains exactly what the change entails, how to get official Texas Prescription Program pads, and the status of e-prescribing for Schedule II drugs.